Boomerang Medical

03/20/2026

Living with ulcerative colitis means managing symptoms that don't follow a schedule.

Pain. Urgency. Fatigue. The kind of unpredictability that makes planning anything feel uncertain.

BOOM-IBD2 is a clinical trial studying an investigational nerve stimulation device for individuals diagnosed with ulcerative colitis.

If you or someone you know is living with UC and wants to learn more, visit the link below.

https://www.crohnscolitisfoundation.org/boom-ibd2-clinical-trial-to-evaluate-the-effectiveness-of-sacral-neuromodulation-the-treatment-of

What symptom has had the biggest impact on your daily life?

03/13/2026

The gut-brain axis isn't a metaphor. It's a two-way communication network.

Your gut and brain are in constant conversation — through the nervous system, hormones, and immune signals.

That communication system plays a significant role in how the gut functions, including the signals that drive urgency.

Bioelectronic therapy works by targeting that network — using precise nerve stimulation rather than a broad pharmacological intervention.

Boomerang Medical is running a pivotal trial studying whether that approach can meaningfully improve the symptoms that most affect quality of life for Ulcerative Colitis patients.

03/11/2026

Clinical Trials: Built Around Patient Safety
Every clinical study follows strict safeguards, including:
• Institutional Review Board (IRB) oversight
• Detailed eligibility criteria
• Continuous safety monitoring
• Transparent data review
Clinical research is how new therapies move from promising ideas to evidence-based care.
We’re proud to partner with experienced investigators and coordinators who uphold the highest standards for patient safety and data integrity.

03/10/2026

Meet the people behind the mission. Our leadership team.

Our work is driven by the patients who are still waiting for better options. Every day we focus on delivering high-quality evidence with integrity and urgency.
Our team brings together expertise across clinical research, engineering, and patient care, all united by one goal: advancing meaningful innovation responsibly.
Stay tuned as we introduce more of the people making this work possible.

02/26/2026

At Boomerang Medical, our mission is simple:
Advance innovative therapies that improve patients’ lives through rigorous clinical research.
This month, we’re excited to kick off our Race to 100 — a milestone campaign recognizing the incredible collaboration between our investigators, study coordinators, and site teams working to bring this therapy to patients.
Every enrollment represents:
✔ A patient seeking new options
✔ A team committed to advancing science
✔ Progress toward evidence that can shape the future of care
We’re grateful to the sites and patients partnering with us on this journey.
🏁 100 patients. One shared mission. Let’s go.

02/04/2026

Today we celebrate National Female Physicians Day- honoring the women who lead with expertise, compassion, and courage.

As a female-led company, Boomerang Medical is proud to partner with extraordinary female physicians who push medicine forward every day. Thank you to our physician partners and colleagues for your leadership, innovation, and unwavering commitment to patients.

01/26/2026

We’re still reflecting on an incredible weekend at the Crohn's & Colitis Foundation Congress.

At Boomerang Medical, our mission is grounded in listening, learning, and partnering with the people who know this space best; patients, physicians, researchers, and advocates. This weekend reinforced just how much progress is being made, and how much more work remains to support those living with IBD.

It was a pleasure connecting with so many leaders in gastroenterology and clinical research—we learned a tremendous amount and truly appreciate the partnership and shared commitment to progress.

12/16/2025

IBD vs. IBS is one of the most common misconceptions in gut health. Understanding the difference in diagnosis is key to better care, awareness, and community.

07/16/2025

We’re grateful to the Crohn's & Colitis Foundation for helping raise awareness about BOOM-IBD2, our new clinical trial studying neuromodulation for people living with ulcerative colitis.

The objective of the BOOM-IBD2 clinical trial is to evaluate the effectiveness of an investigational nerve stimulation (neuromodulation) device for ulcerative colitis (UC). This treatment involves implanting a small electronic device that delivers mild electrical pulses to a nerve near the tailbone....

05/27/2025

Do your IBD symptoms disrupt your daily life? Boomerang Medical is evaluating the effectiveness of investigational sacral neuromodulation for the treatment of Inflammatory Bowel Disease (IBD). See if you qualify: https://bit.ly/3XGIXXz

11/06/2024

For those with inflammatory bowel disease (IBD), stress isn’t just a mental challenge — it can trigger or worsen flare-ups, making an already difficult condition harder to manage. Managing stress is essential for improving quality of life. Whether through mindfulness, exercise, therapy, or simply taking time to relax, stress management plays a crucial role in IBD care.

Let's use today, National Stress Awareness Day, to raise awareness and encourage more conversations about the impacts of stress on health. Taking care of mental health is just as important as taking care of our physical well-being.

If you are a patient with IBD and want to learn about stress management techniques, we recommend visiting the Crohn's & Colitis Foundation for information and resources.👇
bit.ly/4fBvh6M

09/27/2024

We recently reconnected with former Lefteroff Intern Cameron Binney, who interned with us in 2022. Congratulations to Cameron who has since graduated from Auburn University with degrees in Business Analytics and Finance! He is now a financial analyst at Georgia-Pacific in their consumer products division.

During his time with Boomerang Medical and Fogarty Innovation, Cameron worked on multiple projects including an in-depth competitive landscape analysis and pivotal trial endpoint analysis with fellow intern AJ. Together, they researched pivotal trials, documenting various endpoints and mapping out a trial plan.

Cameron shared, “Everyone from the team was very welcoming and willing to answer any questions I might have had. I really enjoyed the internship experience and learned a great deal about the innovative medtech space.”

TeamBoom is thrilled to hear about your accomplishments since your internship, Cameron! We know you will continue to achieve great things.